The findings arrive after a swirl of regulatory uncertainty surrounding the trivalent (three-strain) vaccine, mRNA-1010.

High-dose recombinant influenza vaccine elicits stronger immune responses against A(H3N2) than standard-dose vaccines in healthy young adults.

Randomized trial shows superiority in adults 50 and older ...

Egg- and non-egg-based influenza vaccines showed equivalent protection against laboratory-confirmed influenza‑like illness and related hospitalizations among healthy adults in the military health ...

As flu season approaches, everyone should take precautions to avoid contracting the virus, which can significantly impact your health. Dr. Pedro Piedra, professor of molecular virology and ...

Every year, scientists develop influenza vaccines to help protect people from contracting the flu. However, the flu virus constantly evolves, so the vaccines must change accordingly. Egg-based ...